The Purdue University Board of Trustees has approved the naming of the Evan and Sue Ann Werling Comparative Oncology Research Center in recognition of the donors’ $10 million gift. The center, part of ...

The American Recovery and Reinvestment Act of 2009 provided $1.1 billion for comparative effectiveness research (CER). The Patient Protection and Affordable Care Act established the Patient-Centered ...

Comparative effectiveness research has been the target of recurrent criticism in some political circles, with opponents claiming it’s the “gateway to rationing” or it encourages “cookbook medicine.” ...

Cancer is extremely political and extremely emotional. That makes a discussion on the economics of cancer treatment tricky. Further, the cost and value of cancer therapies are not discussed properly.

Pain shapes survival, behavior, and welfare across species, yet many key questions about how pain starts, persists, and ...

In the Comparative Medicine shared resource at Fred Hutch, our work is guided by scientific purpose and ethical care. We are dedicated to supporting scientists in their pursuit to eliminate cancer and ...

Rigorous scientific standards are needed to address the challenge of providing information on the real-world effects of treatments and procedures. With enactment of healthcare reform legislation now a ...

A Comparative Effectiveness Research (CER) study shows that surgery is better than medical treatment for a particular cardiac condition. My patient is 78 years old and has complicated diabetes. – does ...

Deborah Knapp, distinguished professor of comparative oncology, the Dolores L. McCall Professor of Comparative Oncology and director of the Evan and Sue Ann Werling Comparative Oncology Research ...

The Patient-Centered Outcomes Research Institute (PCORI) has approved funding awards totaling more than $156 million for new patient-centered comparative clinical effectiveness research (CER), as well ...